|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/22/24 DarioHealth Corp. S-3 5:319K Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: S-3 Registration Statement - Securities for a HTML 258K
Transaction
2: EX-5.1 Opinion of Counsel re: Legality HTML 10K
3: EX-23.1 Consent of Expert or Counsel HTML 5K
4: EX-23.2 Consent of Expert or Counsel HTML 5K
5: EX-FILING FEES Filing Fees HTML 11K
Exhibit 107
Calculation of Filing Fee Tables
S-3
(Form Type)
DarioHealth Corp.
(Exact Name of Registrant
as Specified in its Charter)
| Security Type |
Security Class Title | Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit (1) |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee | |
| Fees to Be Paid |
Equity | Common Stock, $0.0001 par value per share (2)(3) |
457(c) | 15,727,223 | $1.195 | $18,794,031.49 | $147.60 per $1,000,000 |
$2,774 |
| Total Offering Amounts | $18,794,031.49 | $2,774 | ||||||
| Total Fees Previously Paid | -- | |||||||
| Total Fee Offsets | -- | |||||||
| Net Fee Due | $2,774 | |||||||
| (1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices for a share of the Registrant’s Common Stock as reported on the Nasdaq Capital Market on April 16, 2024, which date is a date within five business days of the filing of this registration statement. | |
| (2) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. | |
| (3) | Represents 15,759,276 shares of the registrant’s Common Stock consisting of (i) 8,354,097 shares of the registrant’s Common Stock issuable upon conversion of outstanding shares of Series C Convertible Preferred Stock; (ii) 1,980,200 shares of the registrant’s Common Stock issuable upon conversion of outstanding shares of Series C-1 Convertible Preferred Stock; (iii) 521,031 shares of the registrant’s Common Stock issuable upon conversion of outstanding shares of Series C-2 Convertible Preferred Stock; and (iv) 4,880,895 shares of the registrant’s Common Stock issuable as dividends to holders of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock and Series C-2 Convertible Preferred Stock. |
| This ‘S-3’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/22/24 | 8-K | ||
| 4/16/24 | 8-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/03/24 DarioHealth Corp. S-3/A 2:41K Toppan Merrill/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/22/24 DarioHealth Corp. 8-K:2,9 2/15/24 12:1M Toppan Merrill/FA 4/19/24 DarioHealth Corp. 8-K:5,9 4/16/24 12:416K Toppan Merrill/FA 4/05/24 DarioHealth Corp. 8-K:5,9 4/04/24 11:204K Toppan Merrill/FA 3/28/24 DarioHealth Corp. 10-K 12/31/23 102:14M Toppan Merrill Bridge/FA 3/01/24 DarioHealth Corp. 8-K:8 3/01/24 10:184K Toppan Merrill/FA 2/22/24 DarioHealth Corp. 8-K:7,9 2/22/24 11:6.4M Toppan Merrill/FA 2/21/24 DarioHealth Corp. 8-K:1,2,3,5 2/15/24 23:8.3M Toppan Merrill/FA 2/25/16 DarioHealth Corp. 8-A12B 1:15K Toppan Merrill/FA |